Malignancy and radiation-induced cardiotoxicity

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 11, Issue 2, 2011, Pages 102-108

  Mancuso, Luigi ^a   Mancuso, Andrea ^b   Scordato, Francesca ^c   Pieri, Michela ^c   Valerio, M C Eliana ^c  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c Clinica Candela   (Italy)

Author keywords

Breast cancer; Cardiomyopathy; Cardiovascular risk; Constrictive pericarditis; Lymphoma; Radiation Therapy; Stroke; Thymoma

Indexed keywords

ATRIOVENTRICULAR BLOCK; BREAST CANCER; CANCER RADIOTHERAPY; CARDIOTOXICITY; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DEFIBRILLATOR; ENDOTHELIAL DYSFUNCTION; HEART BUNDLE BRANCH BLOCK; HEART MUSCLE CONDUCTION SYSTEM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; LYMPHOMA; MYOCARDIAL DISEASE; NEOPLASM; OXIDATIVE STRESS; PACEMAKER FAILURE; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PERICARDIECTOMY; PERICARDITIS; RADIATION INDUCED CARDIOMYOPATHY; RADIATION INDUCED CARDIOTOXICITY; RADIATION INDUCED CORONARY ARTERY DISEASE; RADIATION INDUCED PERICARDIAL DISEASE; RADIATION INDUCED VALVULAR DISEASE; RADIATION INJURY; RESTRICTIVE CARDIOMYOPATHY; REVIEW; STROKE; THORAX RADIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; VALVULAR HEART DISEASE; CARDIOVASCULAR DISEASE; COMPLICATION; RISK FACTOR;

CARDIOTOXICITY; CARDIOVASCULAR DISEASES; HUMANS; NEOPLASMS; RISK FACTORS;

EID: 83455247303     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152911798347052     Document Type: Review

References (66)

1. Yusuf, S.W.; Sami, S.; Dahari. N. Radiation-induced heart disease: A clinical update. Cardiol. Res. Pract., 2011, Art ID, 31759, 1-9.
2. Bleyer, W.A. The impact of childhood cancer on the United States and the world. Ca: A Cancer Journal for clinician, 1990, Col 40 n6, 355-67.
3. Hancock, S.L.; Donaldson, S.S.; Hoppe, R.T. Cardiac diseases following treatment of Hodgkin's disease in children and adolescents. J. Clin. Oncol., 1993, 11, 1208-15.
4. Adams, M.J.; Lipsitz, S.R.; Colan, S.D.; Tarbell, N.J.; Treves, S.T.; Diller, L.; Greenbaum, N.; Mauch, P.; Lipshultz, S.C. Cardiovascular status in long-term survivors of Hogkin's disease treated with chest radiotherapy. J. Clin. Oncol., 2004, 22, 3139-48.
5. Chera, S.; Rodriguez, C.; Morris, C.G.; Louis, D.; Yeung, D.; Li, Z.; Mendenhall, N.P. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: Conventional radiotherapy, Intensity-modulated radiotherapy, and three-dimensional proton RadiotherapyInt. J. Radiation Oncology Biol. Phys., 2009, 75, 1173-80.
6. Hooning, M.J.; Botma, A.; Anelam, B.M.; Baaijens, M.H.; Bartelink, H.; Klijn, J.G.; Taylor, C.W., van Leeuen, F.E. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J. Nat. Cancer. Inst., 2007, 99, 365-75.
7. Harris, E.E. Cardiac mortality and morbidity after breast cancer treatment. Cancer Control., 2008, 15, 120-29.
8. Shapiro, C.L.; Hardenberg, P.H.; Gelman, R.; Blanks, D.F.; Henderson, H.J. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J. Clin. Oncol., 1998, 16, 3493-501.
9. Gagliardi, G.; Constine, L.S.; Moiseenko, V.; Correa, C.; Pierce, L.J.; Allen, A.M.; Marks, L.B. Radiation dose-volume effects in the heart. Int. J. Radiation Oncology Biol. Phys., 2010, 76, S77-85.
10. Paris, F.; Fuks, Z.; Kang, A.; Capodieci, P.; Ehleiter, D.; Friedman-Haimovitz, A.; Cordon-Cardo, C.; Kolesnick, R. Endothelial apoptosis as the primary lesion initiating radiation damage in mice. Science, 2001, 293, 293-97.
11. Amromin, G.D.; Gildenhorn, H.L.; Salomon, R.D.; Nadkarni, B.B. The synergism of X-irradiation and cholesterol-fat feeding on the development of coronary artery lesions. J. Atherosclerosis Res., 1964, 4, 325-34.
12. Tribble, D.L.; Barcellos-Hoff, B.M.; Chu, B.M.; Gong, E.L. Ionizing radiation accelerates aortic lesion formation in fat-fed mice via SOD-inhibitable processes. Arterioscler. Thromb. Vasc. Biol., 1999, 19, 1387-92.
13. Weintraub, N.L.; Jones, W.K.; Manka, D. Understanding radiationinduced vascular disease. J. Am. Coll. Cardiol., 2010, 55, 1237-39.
14. Zhou, Q.; Zhao, Y.; Li, P.; Bai, X.; Ruan, C. Thrombomodulin as a marker of radiation-induced endothelial cell injury. Radiat. Res., 1992, 131, 285-89.
15. Sigihara, T.; Hattori, Y.; Yamamoto, J.; Fazhi, G.I.; Ichikawa, R.; Sato, A.; Liu, M-Y.; Kazuhiro, A.; Kanno, M. Preferential impairment of nitric oxide-mediated endothelium-dependent relaxation in human cervical arteries after irradiation. Circulation, 1999, 100, 635-41.
16. Carver, J.R.; Shapiro, C.L.; Jacobs, Ng. A.; Schwaryz, C.; Vrgo, K.S.; Hagerty, K. L.; Somerfield, M.R.; Vaughan, D.J. ASCO Cancer Survivorship Expert Panel. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J. Clin. Oncol., 2007, 25, 3991-4008.
17. Veinot, J.P.; Edwards, W.D. Pathology of radiation-induced heart disease; a surgical and autopsy study of 27 cases. Human Pathology, 1996, 27, 766-73.
18. Heidenreich, P.A.; Kapoor, J.R. Radiation induced heart disease. Heart, 2009, 95, 252-58.
19. Morton, D.L.; Glancy, D.L.; Joseph, W.L.; Adkins, P.C. Management of patients with radiation induced pericarditis with effusion: a note on the development of aortic regurgitation in two of them. Chest, 1973, 64, 291-97.
20. Applefeld, M.M.; Cole, J.F.; Pollock, S.H. The late appearance of chronic pericarditis disease in patients treated by radiotherapy for Hodgkin's disease. Annals of internal medicine, 1981, 94, 338-41.
21. Ling, L.H.; Oh, J.K.; Schaff, H.V.; Danielson, G.K.; Mahoney, D.W.; Seward, J.B.; Tajik, A.J. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation, 1999, 100, 1380-86.
22. Heidenreich, P.A.; Hancoch, S.L.; Lee, B.K.; Mariscal, C.S.; Schnitter, I. Asymptomatic cardiac disease following mediastinal irradiation. J. Am. Coll. Cardiol., 2003, 42, 43-9.
23. Heidenreich, P.A.; Hancock, SL.; Vagelos, R. H.; Lee, B.K.; Schnittger, I. Diastolic dysfunction after mediastinal irradiation. Am. Heart. J., 2005, 150, 977-82.
24. Brosius, B.F.; Waller, B.F.; Roberts, W.C. Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. Am. J. Med., 1981, 70, 519-30.
25. Carlson, R.G.; Mayfield, W.R.; Normann, S.; Alexander, J.A. Radiation-associated valvular diseases. Chest, 1991, 99, 538-45.
26. Tamura, A.; Takahara, Y.; Mogi, K.; Katsumata, M. Radiationinduced valvular disease is the logical consequence of irradiation. Gen. Thorac. Cardiovasc. Surg., 2007, 55, 53-56.
27. Slama, M.S.; Le Guludec, D.; Sebag, C.; Leenhardt, A.R.; Davy, J.M.; Pellerin, J.M.; Drieu, L.H.; Victor, J.; Brechenmaker, C.; Mottè, G. Complete atrioventricular block following mediastinal irradiation: a report of six cases. Pacing. Clin. Electrophysiol., 1991, 14, 1112-18.
28. Charniot, J.C.; Zerhouni, K.; Kidouche, R.; Nescimbeni, L.; Gardjbakhch, I.; Artigou, J. Y. Late cardiac complications of radiation therapy. Press Med., 2006, 35, 239-42.
29. Orzan, A.; Brusca, A.; Conte, M.R.; Presbitero, P.; Figliomeni, M.C. Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment. Br. Heart J., 1993, 69, 496-500.
30. Lipshultz, S.E.; Sallan, S.E. Cardiovascular abnormalities in longterm survivors of childhood malignancy. J. Clin. Oncol., 1993, 11, 1199-203.
31. Boivin, J. F.; Hutchison, G. B.; Lubin, J. H.; Mauch, P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer, 1992, 69, 1241-47.
32. Hancock, S.L.; Tucker, M.A.; Hoppe, R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. J. Am. Med. Assoc., 1993, 270, 1949-55.
33. Henry-Amar, M.; Hayat, M.; Meerwaldt, J.H.; Burges, M.; Carde, P.; Somers, R.; Noordijk, M.M.; Monconduit, M.; Thomas, J.; Cosset, J.M. Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative Group. Int. J. Radiat. Oncol. Phys., 1990, 19, 1155-7.
34. Roychoudhuri, R.; Robinson, D.; Putcha, V.; Darby, S.; Maller, H. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer, 2007, 15, 7-9.
35. Patt, D.A.; Goodwin, J.S.; Kuo, Y.F.; Freeman, J.L.; Bucholz, T.A.; Hortobagy, G.N.; Giordano, S.H. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J. Clin. Oncol., 2005, 23, 7475-82.
36. Bouillon, K.; Haddy, N.; Delaloge, S.; Garbay JR.; Garsi J-Ph.; Brindel, P.; Mousannif, A.; Le, M. G.; Labbe, M.; Arriagada, R.; Jougla, E.; Chavaura, J.; Diallo, I.; Rubino, C.; de Vathaire, F. Long-term cardiovascular mortality after radiotherapy for breast cancer. J. Am. Coll. Cardio., 2011, 57, 445-52.
37. Taylor, C.W.; Nisbet, A.; McGale, P.; Darby, S.C. Cardiac exposures in breast cancer radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 2007, 69, 1484-95.
38. Taylor, C.W.; Povall, J.M.; McGale, P.; Nisbet, A.; Dodwell, D.; Smith, J.T.; Darby, S.C. Cardiac dose from tangential breast cancer radiotherapy., Int. J. Radiat. Oncol. Biol. Phys., 2008, 72, 501-7.
39. Witteles, B. Radiation therapy for breast cancer. J. Am. Col. Cardiol., 2011, 57, 453-4.
40. Preston, D.L.; Shimizu, Y.; Pierce, D.A.; Suyama, A.; Mabuchi, K. Studies of mortality of atomic bomb survivors. Radiat. Res., 2003, 160, 381-407.
41. Huddart, R.A.; Norman, A.; Shahidi, M.; Horwich, A.; Coward, D.; Nichols, J.; Dearnaley, D.P. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J. Clin. Oncol., 2003, 21, 1513-23.
42. Veronesi, U.; Marubini, E.; Mariani, L.; Valagussa, P.; Zucali, R. The dissection of internal mammary nodes does not improve the survival of breast cancer patients., Eur. J. Cancer, 1999, 35, 1320-25.
43. Pignol, J-Ph.; Keller, B.M.; Ravi, A. Dose to internal organs for various breast radiation techniques-implications on the risk of secondary cancers and cardiomyopathy. Rad. Oncol., 2011, 6, 1-6.
44. Hardy, D.; Liu, C.C.; Cormier, J.N.; Xia, R.; Du, X.L. Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer. Ann. Oncol., 2010, 21, 1825-33.
45. Gharagozloo, F.; Clemets, I.P.; Mullany, C.J. Use of the internal mammary artery for myocardial revascularization in a patient with radiation-induced coronary artery disease. Mayo Clin. Proc., 1992, 67, 1081-84.
46. Schulman, H.E.; Korr, K.S.; Myers, T.J. Left internal thoracic artery graft occlusion following mediastinal radiation therapy. Chest, 1994, 105, 1881-82.
47. Hughes-Davies, L.; Sacks, D.B.; Rescigno, J.; Howard, S.; Harris, J. Serum cardiac troponin T levels during treatment of early-stage breast cancer. J. Clin. Oncol., 1995, 13, 2582-84.
48. Kozak, K.R.; Hong, T.S.; Sluss, P.M.; Lewandroski, E.L.; Aleryani, S.L.; Macdonald, S.M.; Choi, N.C.; Yock, T.I. Cardiac blood biomarkers in patients receiving thoracic (chemio) radiation. Lung Cancer, 2008, 62, 351-55.
49. Hicks, G.L. Coronary artery operation in radiation-associated atherosclerosis: long-term follow up. Ann. Thorac. Surg., 1992, 53, 670-74.
50. van Son, J.A.; Noyez, L.; van Asten, W.N. Use of internal artery in myocardial revascularization after mediastinal irradiation. J. Thorac. Cardiovasc. Surg., 2007, 104, 1539-44.
51. Schomig, K.; Ndrepepa, G.; Mehili, J.; Kasfrati, A.; Schomig A. Thoracic radiotherapy in a patient with lymphoma and restenosis after coronary stent placement. Catheter. Cardiovasc. Interv., 2007, 70, 359-65.
52. Kaluza, G.L.; Raizner, A.E. Brachytherapy for restenosis after stenting for coronary artery disease: its role in the drug-eluting stent era. Curr. Opin. Cardiol., 2004, 19, 601-07.
53. Dubois, C.L.; Pappas, C.; Belmans, A.; Erven, K.; Adriaenssens, T.; Sinnaeve, P.; Coosermans, M.; Kayaert, P.; Weltens, C.; Desmet, W. Clinical outcome of coronary stenting after thoracic radiotherapy: a case-control study. Heart, 2010, 96, 678-82.
54. Hull, M.C.; Morris, C.G.; Pepine, C.J.; Mendenhall, N.P. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. J. Am. Med. Ass., 2003, 290, 2831-37.
55. De Bruin, M.L.; Dorresteijn, L.D.A.; van't Veer, M.B.; Krol, A.D.; van der Pal, H.J.; Kappelle, A.C.; Boogerd, W.; Aleman, B.M.; val Leeuwen, F.E. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin Lymphoma. J. Nat. Cancer Inst., 2009, 100, 928-37.
56. Bowers, D.C.; McNeill, D.E.; Liu, Y. et al. Stroke as a late treatment effect of Hodgkin's disease: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol., 2005, 23, 6508-15.
57. Schultz-Hector, S.; Trott, K.R. Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? Int. J. Radiat. Oncol. Biol. Phys., 2007, 67, 10-18.
58. Longo, D.L. Late effects from radiation therapy: the hits just keep on coming. J. Nat. Cancer Inst., 2009, 101, 904-5.
59. Nemec, J. Runaway implantable defibrillator-a rare complication of radiation therapy. PACE, 2007, 30, 716-18.
60. Tsekos, A.; Momm, F.; Brunner, M.; Guttemberger, R. The cardiac pacemaker patient-might the pacemaker be directly irradiated? Acta Oncol., 2000, 39, 881-83.
61. Hoecht, S.; Rosenthal, P.; Sancar, D.; Behrens, S.; Hinkelbein, W.; Hoeller, U. Implantable cardiac-defibrillator may be damaged by radiation therapy? J. Clin. Oncol., 2002, 8, 2212-13.
62. Hurkmans, C.W.; Scheepers, E.; Springorum, B.; Uiterwaal, H. Influence of radiotherapy on the latest generation of implantable cardioverter-defibrillators. Int. J. Radiat. Oncol. Biol. Phys., 2005, 63, 282-89.
63. Thomas, D.; Becker, R.; Katus, H.A.; Schoels, W.; Karle, C.A. Radiation therapy-induced electrical reset of an implantable cardioverter defibrillator device located outside the irradiation field. J. Electrocardiol., 2004, 1, 73-74.
64. John, J.; Kaye, G.C. Shock coil failure secondary to external irradiation in a patient with implantable cardioverter defibrillator. PACE, 2004, 27, 690-91.
65. Marbach, J.R.; Sontag, M.R.; Van Dyk, J; Wolbarst, A.B. Management of radiation oncology patients with implanted cardiac pacemakers: report of AAPM Task Group no 34. Med. Phys., 1994, 21, 85-90.
66. Hudson, F.; Coulshed, D.; D'Souza, E.; Baker, C. Effect of radiation therapy on the latest generation of pacemakers and implantable cardioverter defibrillators: a systematic review. J. Med. Imag. Radiat. Oncol., 2010, 54, 53-61.